This inventor holds 3 USPTO granted patents. Top assignee: Syntex (u.s.a.) Inc.. Active years: 2002-2005.
Company Filing History:
Years Active: 2002-2005
Title: Innovations by Leslie Ann Robinson in Pharmaceutical Chemistry
Introduction
Leslie Ann Robinson, an accomplished inventor based in Los Altos, California, has made significant contributions to the field of pharmaceutical chemistry. With a commendable portfolio boasting three patents, Robinson has focused on the development of sulfonamide-based compounds that offer promising therapeutic applications.
Latest Patents
Among her recent inventions, Leslie's patents primarily concentrate on sulfonamide derivatives. Her latest patents include:
1. **Sulfonamide Hydroxamates** - This invention relates to certain sulfonamide derivatives that inhibit procollagen C-proteinase. It encompasses pharmaceutical compositions containing these compounds, methods for their use, and methods for preparing them.
2. **Sulfonamide Compounds** - Similar to her previous patent, this invention also focuses on sulfonamide derivatives as inhibitors of procollagen C-proteinase, along with the necessary formulations and preparation methods.
Career Highlights
Robinson's impressive journey in the field is marked by her work at Syntex (U.S.A.) Inc., where she has been instrumental in driving innovation through her research and development efforts. Her expertise in sulfonamide compounds showcases her dedication to advancing pharmaceutical technologies.
Collaborations
Throughout her career, Leslie has collaborated with esteemed colleagues, including Roland Joseph Billledeau and Chris Allen Broka. These partnerships have further enriched her research endeavors and enhanced the impact of her innovations in the pharmaceutical sector.
Conclusion
Leslie Ann Robinson continues to be a pivotal figure in the field of pharmaceutical chemistry, with her inventions contributing to important advancements in therapeutic solutions. Her focus on sulfonamide derivatives underscores her role as a key innovator, shaping the future of drug development and healthcare.